JPRN-jRCT2063200044已完成1 期
Phase I Study of Combination Therapy with OBP-301, Atezolizumab and chemoradiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck Cancer
Fujiwara Toshiyoshi0 个研究点目标入组 23 人开始时间: 2021年1月14日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 23
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with the oral cavity, oropharynx, larynx, or hypopharynx histologically or cytologically confirmed who are unresectable or wishing organ preservation
- •- When oropharynx cancer, HPV status is determined
- •- Definitive chemoradiotherapy of CDDP and IMRT are indicated.
- •- ECOG Performance Status (PS) is 0 to 1.
排除标准
- •- The stage for primary tumor or cervical nodes is unknown.
- •- Prior treatment with definitive local therapy or systemic therapy for the head and neck cancer.
- •- Prior treatment with radiotherapy over the cranial base to clavicle.
研究者
相似试验
终止
1 期
Phase I Study of Combination Therapy with OBP-301 and Chemoradiotherapy in Patients with Locally Advanced Esophageal Canceresophageal cancerJPRN-jRCT1080225198Chugai Pharmaceutical Co., Ltd.20
已完成
2 期
Phase II Study of Combination Therapy with OBP-301 and Radiotherapy in Patients with Locally Advanced Esophageal Canceresophageal carcinomaJPRN-jRCT1080225033Oncolys BioPharma Inc.37
已完成
1 期
Phase I Study of Combination Therapy with OBP-301, Atezolizumab and Bevacizumab in Patients with Hepatocellular CarcinomaHepatocellular carcinomaJPRN-jRCT2033200223Doi Toshihiko4
Unknown
1 期
A Study of OBP-301 With Radiation Therapy in Patients With Esophageal CancerEsophageal CancerNCT03213054Oncolys BioPharma Inc12
招募中
1 期
Phase I/II trial of combined chemotherapy of Nab-paclitaxel, S-1, and Oxaliplatin for gastric cancer patients with peritoneal metastasis (NSOX study)gastric cancer with peritoneal metastasisJPRN-UMIN000030909Wakayama Medical University, School of Medicine35